Clinical trials: Fluoxetine
Hepatobiliary Malignancy, Fluoxetine
SSRI Antidepressant Fluoxetine Improving Immunotherapy Efficacy in Advanced Hepatobiliary Malignancy Patients With Depression and Anxiety
Advanced liver and gallbladder malignancies (including liver cancer, cholangiocarcinoma and gallbladder cancer) are a type of disease that is difficult to treat, and most patients have a short survival period.
- Conditions
- Hepatobiliary Malignancy, Fluoxetine, Anxiety Disorders, Depression Disorders
- Trial name
- NCT07174947
- Testing
- Fluoxetine (drug)
- Where
- China
- Volunteers
- 240 people
- Sponsor
- First Affiliated Hospital of Wenzhou Medical University
Constipation - Functional, Refractory Constipation
Predicting Treatment Outcomes in Refractory Constipation Through Brain Connectivity Evaluation
The goal of this observational study is to identify the characteristics of brain functional connectivity in refractory constipation and fluoxetine-sensitive patients.
- Conditions
- Constipation - Functional, Refractory Constipation, Fluoxetine, fMRI
- Trial name
- NCT06221722
- Testing
- BOLD-fMRI, Regular treatment of functional constipation, fluoxetine
- Where
- 3 sites in China
- Volunteers
- 150 people, healthy volunteers welcome
- Sponsor
- Xijing Hospital of Digestive Diseases
Fluoxetine
Study on the Optimal Strategy of Chinese Patients With Bulimia Nervosa After Fluoxetine Treatment
Current treatment strategies for BN are limited. The total effective rate of pharmacotherapy and psychotherapy is only about 50%.The preliminary studies and clinical experience of this project indicate that :(1) fluoxetine, DBT…
- Trial name
- NCT04154813
- Testing
- Topiramate, Fluoxetine, cognitive behavioral therapy (CBT)
- Where
- China
- Volunteers
- 550 people
- Sponsor
- Shanghai Mental Health Center
Major Depressive Disorder, Antidepressive Agents
Pharmacogenomics Studies of Antidepressants
The purpose of this study is to establish the clinical effectiveness of antidepressants by pharmacogenomic approach, and to determine the levels of inflammatory factors between the baseline and the end point of the study in…
- Conditions
- Major Depressive Disorder, Antidepressive Agents, Pharmacogenetics, Venlafaxine
- Trial name
- NCT01204086
- Testing
- Venlafaxine, Fluoxetine
- Where
- Taiwan
- Volunteers
- 200 people
- Sponsor
- National Cheng-Kung University Hospital